Avai Bio annual gross margin
2020
2023
Avai Bio's gross margin was −14.64% for fiscal 2023.
View full Avai Bio company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-03-31 | −14.64% | +3.22 pp |
| 2020 | 2020-03-31 | −17.86% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2021 | 2020-12-31 | 111.83% | — |
| Q2 2021 | 2020-09-30 | 12.32% | — |
| Q1 2021 | 2020-06-30 | 14.14% | — |
Across the available reported history, Avai Bio's gross margin increased from −17.86% to −14.64%, a change of +3.22 percentage points. The latest reported quarter, Q3 2021, shows 111.83%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Avai Bio filings at SEC.gov ↗